Ildiko Csiki
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 2
- Immunology 10
- Immunotherapy and Immune Responses 9
- Co-authors
- Jason D. Morrow (6 shared papers)David P. Carbone (7 shared papers)David H. Johnson (5 shared papers)John A. Oates (1 shared paper)David H. Johnson (1 shared paper)Laine J. Murphey (1 shared paper)Stephanie Sanchez (1 shared paper)Loretta M. Byrne (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Annals of Oncology (4 papers)Clinical Cancer Research (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Nature Medicine (1 paper)
- Partner nations
- United StatesNew Zealand
In The Last Decade
Ildiko Csiki
24 papers receiving 680 citations
Ildiko Csiki's Hit Papers
Peers
Comparison fields: 5 of 84
- Pharmacology 203
- Biochemistry 54
- Cancer Research 101
- Oncology 171
- Immunology 132
Countries citing papers authored by Ildiko Csiki
This map shows the geographic impact of Ildiko Csiki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ildiko Csiki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ildiko Csiki more than expected).
Fields of papers citing papers by Ildiko Csiki
This network shows the impact of papers produced by Ildiko Csiki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ildiko Csiki. The network helps show where Ildiko Csiki may publish in the future.
Co-authors
The 25 scholars most cited alongside Ildiko Csiki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 142 | |
| 2 | Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial Hit paper breakdown → | 2024 | 134 |
| 3 | 2005 | 91 | |
| 4 | 2006 | 80 | |
| 5 | 2009 | 72 | |
| 6 | 2009 | 72 | |
| 7 | 2010 | 19 | |
| 8 | 2010 | 16 | |
| 9 | 2012 | 14 | |
| 10 | 2021 | 8 | |
| 11 | 2017 | 7 | |
| 12 | 2021 | 6 | |
| 13 | 2017 | 6 | |
| 14 | 2023 | 6 | |
| 15 | 2022 | 5 | |
| 16 | 2002 | 4 | |
| 17 | 2017 | 2 | |
| 18 | 2017 | 1 | |
| 19 | 2009 | 1 | |
| 20 | 2024 | 1 |
About Ildiko Csiki
Ildiko Csiki is a scholar working on Oncology, Immunology, Molecular Biology, Pharmacology and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 691 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Inflammatory mediators and NSAID effects (5 papers), RNA Interference and Gene Delivery (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Prostate Cancer Treatment and Research (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Pharmacology (203 citations), Biochemistry (54 citations), Cancer Research (101 citations), Oncology (171 citations) and Immunology (132 citations). Ildiko Csiki has collaborated with scholars based in United States and New Zealand. Frequent co-authors include Jason D. Morrow, David P. Carbone, David H. Johnson, John A. Oates, David H. Johnson, Laine J. Murphey, Stephanie Sanchez, Loretta M. Byrne, Yu Shyr and Misun Hwang. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.